BILL ANALYSIS                                                                                                                                                                                                    �




                     SENATE GOVERNANCE & FINANCE COMMITTEE
                            Senator Lois Wolk, Chair
          

          BILL NO:  SB 626                      HEARING:  5/4/11
          AUTHOR:  Calderon                     FISCAL:  Yes
          VERSION:   4/25/11                    TAX LEVY:   No
          CONSULTANT:  Miller                   

                   CANNABIS CERTIFICATION & REGULATION STUDY
          

          Proposes that the Board of Equalization (BOE) study ways 
          for cannabis sellers to comply with the state's sales and 
          use tax laws. 


                           Background and Existing Law
                                         
          Existing federal law prohibits the manufacture, possession, 
          sale or distribution of marijuana.  Congress enacted the 
          Controlled Substances Act (CSA) as part of the 
          Comprehensive Drug Abuse Prevention and Control Act of 
          1970.  The CSA establishes five "schedules" of certain 
          drugs and other substances designated "controlled 
          substances."  For a drug or other substance to be 
          designated a schedule I controlled substance, it must be 
          found that the substance "has a high potential for abuse," 
          have "no currently accepted medical use in treatment in the 
          United States," and "lack accepted safety for use under 
          medical supervision." Federal law lists marijuana as a 
          schedule I controlled substance, deemed to have no accepted 
          medical use.  



          Existing law, the California Uniform Controlled Substances 
          Act prohibits, except as authorized by law, the possession, 
          cultivation, transportation, and sale of marijuana and 
          derivatives of marijuana.  Existing law authorizes, under 
          the Compassionate Use Act of 1996 (Proposition 215, 1996), 
          a patient or the patient's primary caregiver to cultivate 
          or possess marijuana for the patient's medical use when 
          recommended by a physician, as specified.  



          There is currently no statewide regulatory or licensing 




          SB 626 -- 4/25/11 -- Page 2



          program for the sale and distribution of marijuana.

          Under the existing Sales and Use Tax Law, except where 
          specifically exempted by statute, a tax is imposed on all 
          retailers for the privilege of selling tangible personal 
          property at retail in this state.  Tangible personal 
          property is defined in law to mean any personal property 
          which may be seen weighed, measured, felt, or touched, or 
          which is in any other manner perceptible to the senses.  
          Therefore, under the law, retail sales of marijuana, 
          including medical marijuana, and any other illegal drugs, 
          are subject to tax to the same extent as any other lawful 
          retail sale of tangible personal property.  

          The Sales and Use Tax Law exempts from sales and use tax 
          retail sales of medicines, as defined, when furnished by a 
          health facility for patient treatment pursuant to the order 
          of a certificated physician, or when prescribed by a 
          certificated physician and dispensed on a prescription 
          filled by a registered pharmacist in accordance with law.  
          Medical marijuana dispensaries do not meet the definition 
          of health care facilities provided in that section.  As 
          such, sales of medical marijuana by dispensaries and 
          primary caregivers do not qualify for the exemption, 
          whether or not those purchasers possess a medical marijuana 
          identification card.  And since caregivers and medical 
          marijuana dispensaries generally are not registered 
          pharmacists, their sales of medical marijuana also do not 
          meet the conditions for the exemption. 

          Under the law, every person engaged in the business of 
          selling tangible personal property which are subject to tax 
          is required to apply to the BOE for a seller's permit on a 
          form prescribed by the BOE.  Wholesalers, suppliers, as 
          well as retailers, must obtain a seller's permit.  Any 
          person that engages in business as a seller in this state 
          without a seller's permit and each officer of any 
          corporation which so engages in business, is guilty of a 
          misdemeanor, punishable by a fine of not less than $1,000 
          and not more than $5,000, or imprisonment not exceeding one 
          year in the county jail, or both the fine and imprisonment 
          in the discretion of the court.

          Also, under existing law, persons who fail to file a sales 
          and use tax return and pay their tax obligations may be 
          held liable for past tax obligations, together with 





          SB 626 -- 4/25/11 -- Page 3



          interest and penalties, for up to eight prior years (except 
          in the case of fraud which has no limitation period in 
          which to assess past tax obligations).  




                                   Proposed Law
           
          Senate Bill 626 requires the Board of Equalization to 
          study the most efficient means to create a licensing 
          program for cannabis products in this state in order to 
          collect all the sales and use tax due and owed pursuant 
          to the laws established by Proposition 215, 1996.  Among 
          other considerations, the BOE is required to:
                 Discuss the advantages and disadvantages of a 
               stamping program, similar to the tobacco licensing 
               program.
                 Strategies to identify sellers and encourage them 
               to pay the taxes owed.
                 Strategies to provide incentives to sellers to 
               pay the tax.

          SB 626 also provides various findings and declarations that 
          focus on the issues surrounding Proposition 215: the 
          patients, dispensaries, law enforcement and local 
          government and state the bills intent to mitigate these 
          issues through a state licensing and enforcement practice. 


                               State Revenue Impact
           No estimate.


                                     Comments  

          1.   Purpose of the bill  .  The author introduced this bill 
          to create a mechanism for studying the best ways to 
          control, regulate and test medical marijuana cultivation 
          and distribution.

          2.   What's So Great About Short-Term Memory Anyway?   
          Existing state law, as authorized under the Compassionate 
          Use Act (Proposition 215 of 1996), allows persons or 
          primary caregivers to cultivate or possess marijuana for 
          medical use when recommended by a physician.  Despite 





          SB 626 -- 4/25/11 -- Page 4



          California's law, the sale of medical cannabis is strictly 
          illegal under federal law.  SB 420 (Vasconcellos, 2003) 
          established statewide guidelines for Proposition 215 sales 
          and enforcement.  For example, non-profit distribution is 
          allowed in certain cases for patient cultivation co-ops and 
          small-scale caregiver gardeners.  

          Until 2005, the BOE's longstanding policy was to not issue 
          a seller's permit to a person whose sole selling activity 
          is "the unlawful sale of tangible personal property, so as 
          not to confer permissive authority or condone an illegal 
          activity."  Under existing law, the sales tax applies to 
          all retail sales of even illegal substances in this state 
          and the BOE may audit and make assessments of any 
          unreported tax on such sales.  

          After hearing a case that came before the Members of the 
          BOE involving medical marijuana sales, and recognizing the 
          difficulty in reconciling the BOE's authority to issue 
          assessments for taxes due from a seller's marijuana sales 
          while not issuing seller's permits to such sellers, as well 
          as taking into account the legality of some sales of 
          marijuana as authorized in SB 420, the BOE changed its 
          policy and began issuing seller's permits to sellers of 
          medical marijuana.  The BOE's current practice is to issue 
          seller's permits to those medical marijuana sellers that 
          apply and will also issue seller's permits to any other 
          sellers even those making unlawful sales.  In order to 
          reduce concerns about confidentiality and 
          self-incrimination, the BOE allows an applicant of a 
          seller's permit to omit information normally requested on 
          the application, such as the products the applicant intends 
          to sell, the names and addresses of suppliers, and the 
          products the applicant intends to purchase.  As such, the 
          exact number of dispensaries registered with the BOE is 
          unknown.

          3.   Just Doob It.   Unlike marijuana products, cigarettes 
          are strictly regulated through a "stamping" program in this 
          state.  AB 71 (J. Horton, 2003) enacted the Cigarette and 
          Tobacco Products Licensing Act of 2003 that established a 
          statewide licensure program administered by the BOE to 
          mitigate untaxed distributions and illegal sales of 
          cigarettes and tobacco products.  The Licensing Act, which 
          generates an estimated $153 million annually in additional 
          sales and use, and excise tax, requires the licensure of 





          SB 626 -- 4/25/11 -- Page 5



          all persons engaging in the sale of cigarettes and tobacco 
          products.  The Licensing Act provides recordkeeping 
          requirements, prohibitions on sales and purchases, seizure 
          and inspection authority, and penalties and fines for 
          violations.  

          3.   Up in smoke.   AB 390 (Amiano, 2009) imposed a fee of 
          $50 per ounce of marijuana sold in this state.  The BOE 
          would have administered and collected the fee, with the 
          revenues dedicated to drug education, awareness, and 
          rehabilitation programs.  The bill also required the 
          Department of Alcoholic Beverage Control (ABC) to license 
          both commercial cultivators of marijuana and wholesalers of 
          marijuana, who would be allowed to package and prepare 
          marijuana for sale and would be authorized to sell 
          marijuana to licensed sales outlets.  The bill died in the 
          Assembly Committee on Health without being heard.  AB 2254 
          (Amiano, 2010) was similar to AB 390.  That bill was never 
          heard in the Assembly Committee on Public Safety.  

          SB 6X 17 (Calderon, 2010) enacted a cannabis licensing 
          program similar to the Cigarette and Tobacco Products 
          Licensing Act of 2003.  That bill was never referred to a 
          policy committee for hearing.  SB 1131 (Calderon, 2010), 
          enacted the Sales Tax Enforcement Act of 2010, with the 
          intent to better assist the BOE in collecting the sales tax 
          generated by marijuana sales.  That bill died in Assembly 
          Rules without referral to a policy committee.

          4.   Learn to focus better.   Despite multiple attempts to 
          regulate the sales and use tax of medical marijuana, there 
          is still no simple method to invoice the product much less 
          know exactly who the sellers are.  Furthermore, the state 
          still does not fully understand all of the implications of 
          Proposition 215 vis-�-vis state law requirements especially 
          how to ensure that sellers do not incriminate themselves at 
          the federal level by complying with state law.  Due to the 
          complicated nature of the issue, it makes sense to study 
          the best ways to enforce the law instead of creating a new 
          law that would not only be costly to administer but also 
          impossible to enforce. 

          5.   Go to the experts.   In order to make sure that the 
          study is vetted and comprehensive, the Committee may wish 
          to consider amending the bill to include an advisory 
          committee of experts on the topic of medical marijuana, 





          SB 626 -- 4/25/11 -- Page 6



          including law enforcement experts, to assist in the 
          compilation of the study.  This advisory committee should 
          not be paid for out of state funds but rather be a 
          volunteer service.  The following representatives should 
          make up the advisory committee: A representative from the 
          California Police Chiefs' Association
             1.   A representative from the California Narcotics 
               Officers' Association
             2.   A representative from the California District 
               Attorneys' Association
             3.   A representative from the California Medical 
               Association
             4.   A representative appointed by the Attorney General
             5.   A representative from the California Cannabis 
               Association
             6.   A representative from Americans for Safe Access
             7.   Two representatives appointed by the Chair of the 
               BOE

          6.   Technical amendments.   The author will offer technical 
          amendments in committee to correct spelling errors and 
          provide for a study of wholesale and retail dispensaries.  

                         Support and Opposition  (4/28/11)

           Support  :  CA Cannabis Association.

           Opposition  :  Drug Policy Alliance